Search research articles
Contact Us
Filters
Showing results (151-160 of 160) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 160 results.
Journal of Nephrology
|
March 13, 2021
Nomenclature in nephrology: preserving 'renal' and 'nephro' in the glossary of kidney health and disease
Kamyar Kalantar-Zadeh, Peter A McCullough, Sanjay Kumar Agarwal, et al.
Autoimmunity Reviews
|
September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Rheumatology (Oxford, England)
|
December 10, 2021
Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA
Johanna Dahlqvist, Diana Ekman, Bengt Sennblad, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 8, 2026
Kidney Transplantation in Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Long-Term Outcomes and Prognostic Factors
Giorgio Trivioli, Marco Allinovi, Elio Di Marcantonio, et al.
Kidney International Reports
|
April 29, 2021
Rituximab in Membranous Nephropathy
Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
The New England Journal of Medicine
|
July 20, 2012
Genetically distinct subsets within ANCA-associated vasculitis
Paul A Lyons, Tim F Rayner, Sapna Trivedi, et al.
Annals of the Rheumatic Diseases
|
March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
Rona M Smith, Rachel B Jones, Ulrich Specks, et al.
Kidney360
|
April 4, 2022
COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry
Meryl Waldman, Maria Jose Soler, Clara García-Carro, et al.
Journal of the American Society of Nephrology : JASN
|
October 21, 2024
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies
Philipp Gauckler, Anna Matyjek, Seleni Kapsia, et al.
Annals of the Rheumatic Diseases
|
June 26, 2020
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
Rona M Smith, Rachel Bronwen Jones, Ulrich Specks, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 160) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 160 results.
Journal of Nephrology
|
March 13, 2021
Nomenclature in nephrology: preserving 'renal' and 'nephro' in the glossary of kidney health and disease
Kamyar Kalantar-Zadeh, Peter A McCullough, Sanjay Kumar Agarwal, et al.
Autoimmunity Reviews
|
September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Rheumatology (Oxford, England)
|
December 10, 2021
Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA
Johanna Dahlqvist, Diana Ekman, Bengt Sennblad, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 8, 2026
Kidney Transplantation in Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Long-Term Outcomes and Prognostic Factors
Giorgio Trivioli, Marco Allinovi, Elio Di Marcantonio, et al.
Kidney International Reports
|
April 29, 2021
Rituximab in Membranous Nephropathy
Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
The New England Journal of Medicine
|
July 20, 2012
Genetically distinct subsets within ANCA-associated vasculitis
Paul A Lyons, Tim F Rayner, Sapna Trivedi, et al.
Annals of the Rheumatic Diseases
|
March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
Rona M Smith, Rachel B Jones, Ulrich Specks, et al.
Kidney360
|
April 4, 2022
COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry
Meryl Waldman, Maria Jose Soler, Clara García-Carro, et al.
Journal of the American Society of Nephrology : JASN
|
October 21, 2024
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies
Philipp Gauckler, Anna Matyjek, Seleni Kapsia, et al.
Annals of the Rheumatic Diseases
|
June 26, 2020
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
Rona M Smith, Rachel Bronwen Jones, Ulrich Specks, et al.
Page
of 16